AVE 0.00% 0.2¢ avecho biotechnology limited

financials have been released, page-13

  1. 564 Posts.
    lightbulb Created with Sketch. 1
    yes dougal,

    That's how I read it. There will be a cap raising but it will not fund oxy through to commercialization, rather

    "the completion of a commercial oxycodone patch and
    the commencement of a phase 2 study in the third quarter."


    Funny how all those rosy scenarios didn't play out.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.